Metformin/repaglinide - Novo Nordisk
At a glance
- Drug Originator Novo Nordisk
- Drug Licenced by Shionogi Pharma
- Drug Class Antihyperglycaemics; Biguanides; Carbamates; Piperidines; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants; Potassium channel antagonists
- USA Patent Applicants NOVO NORDISK INC
- USA Patents 2
- NDAs 1
- Patent Applications 130
Table of Contents
Disclaimer